(Q34786801)

4 August 2017

1 reference

title

Drug and ECT treatment of depression in the elderly, 1996-2001: a literature review (English)

1 reference

4 August 2017

1 reference

Carl Salzman

1

1 reference

4 August 2017

Eileen Wong

series ordinal

2

1 reference

4 August 2017

B Cody Wright

series ordinal

3

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

4 August 2017

published in

Biological Psychiatry

1 reference

4 August 2017

volume

52

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

265-284

1 reference

Side effects and time course of response in a placebo-controlled trial of fluoxetine for the treatment of geriatric depression

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Reboxetine in the maintenance therapy of depressive disorder in the elderly: a long-term open study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Recovery in Geriatric Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Long-term treatment of geropsychiatric depressed patients with venlafaxine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Reboxetine in the treatment of depression in the elderly: pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Effects of comorbidity and polypharmacy on the clinical usefulness of sertraline in elderly depressed patients: an open multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Care of depression in the elderly: comparative pharmacokinetics of SSRIs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Recognition and treatment of dysthymia in elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Pharmacokinetics of reboxetine in healthy, elderly volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

The use of dexamethasone in elderly patients with antidepressant-resistant depressive illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

A prospective follow-up study of ECT outcome in older depressed patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Does lorazepam impair the antidepressant response to nortriptyline and psychotherapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Antidepressant drug interactions in the elderly. Understanding the P-450 system is half the battle in reducing risks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Electroconvulsive therapy in the very old

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Treatment of depression in elderly patients: recent advances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Temporal profiles of the course of depression during treatment. Predictors of pathways toward recovery in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

An open-label evaluation of the long-term safety of oral venlafaxine in depressed elderly patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Paroxetine in the elderly: a comparative meta-analysis against standard antidepressant pharmacotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Placebo-controlled treatment trial of depression in elderly physically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Comparative efficacy of sertraline vs. fluoxetine in patients age 70 or over with major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

The effect of treatment on the two-year course of late-life depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

The effect of sequential antidepressant treatment on geriatric depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Effect of demographic and clinical variables on time to antidepressant response in geriatric depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Two-year outcome of elderly patients with anxious depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Choosing appropriate antidepressant therapy in the elderly. A risk-benefit assessment of available agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Recurrence of first-episode geriatric depression after discontinuation of maintenance antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Maintenance treatment for recurrent depression in late life. A four-year outcome study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Nonresponse to first-line pharmacotherapy may predict relapse and recurrence of remitted geriatric depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Resistant depression in the very old--a role for maintenance ECT?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Treatments for late life depression in primary care--a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Conventional and new antidepressant drugs in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Antidepressant drugs in the elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Antidepressant Use in the Elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Fluoxetine in medically stable, depressed geriatric patients: effects on weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Relationships between low red blood cell count and clinical response to fluoxetine in depressed elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

The safety and efficacy of electroconvulsive therapy in patients over age 75

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Recognition and management of depression in the elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Accelerating antidepressant response in geriatric depression: a post hoc comparison of combined sleep deprivation and paroxetine versus monotherapy with paroxetine, nortriptyline, or placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Steady-state pharmacokinetics of citalopram in young and elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Gradual discontinuation of lithium augmentation in elderly patients with unipolar depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Treatment of depression in late life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Psychopharmacological and electroconvulsive treatment of anxiety and depression in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Management of treatment resistance in the depressed geriatric patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Update on electroconvulsive therapy (ECT) in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

The dexamethasone suppression test and treatment outcome in elderly depressed patients participating in a placebo-controlled multicenter trial involving moclobemide and nortriptyline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Predicting response to fluoxetine in geriatric patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

How common is resistance to treatment in recurrent, nonpsychotic geriatric depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Electroconvulsive therapy in old-old patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Effect of paroxetine on plasma vasopressin and water load testing in elderly individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Recognition and management of anxiety and depression in elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Effectiveness of treatments of depression in older ambulatory patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

The effectiveness of antidepressants in elderly depressed outpatients: a prospective case series study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Efficacy and safety of the selective serotonin reuptake inhibitors in treating depression in elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

The effects of perphenazine on the concentration of nortriptyline and its hydroxymetabolites in older patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Moclobemide and nortriptyline in elderly depressed patients. A randomized, multicentre trial against placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

The Influence of Age on the Response of Major Depression to Electroconvulsive Therapy: A C.O.R.E. Report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Heuristic comparison of sertraline with nortriptyline for the treatment of depression in frail elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

The benefits and risks of ECT for patients with primary dementia who also suffer from depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Maintenance nortriptyline effects on electroencephalographic sleep in elderly patients with recurrent major depression: double-blind, placebo- and plasma-level-controlled evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Treatment outcome in recurrent major depression: a post hoc comparison of elderly ("young old") and midlife patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

High relapse rate after discontinuation of adjunctive medication for elderly patients with recurrent major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Treatment of major depression in later life: a life cycle perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Weight outcomes among antidepressant users in nursing facilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Sertraline in the treatment of minor depression in nursing home residents: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Tianeptine therapy for depression in the elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Buspirone and imipramine for the treatment of major depression in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Selective serotonin reuptake inhibitors in older patients. A tolerability perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Recurrence and relapse in geriatric depression: a review of risk factors and prophylactic treatment strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Recovery and relapse in geriatric depression after treatment with antidepressants and ECT in a medical-psychiatric population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Drug treatment of depression in frail elderly nursing home residents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Antidepressants and the risk of falls among nursing home residents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Compliance with antidepressant medication in the treatment of major depressive disorder in primary care: a randomized comparison of fluoxetine and a tricyclic antidepressant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Depression in community-dwelling elders. Overcoming treatment obstacles with new antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Nortriptyline in geriatric depression resistant to serotonin reuptake inhibitors: case series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Differential effects of trimipramine and fluoxetine on sleep in geriatric depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Antidepressant efficacy and cardiovascular safety of venlafaxine in young vs old patients with comorbid medical disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Depression in late life. Special considerations in treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

7 January 2021

Recognition and management of depression in primary care: a focus on the elderly. A pharmacotherapeutic overview of the selection process among the traditional and new antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

7 January 2021

Treatment-resistant depression in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

1 reference

7 January 2021

Acute effects of fluoxetine versus placebo on functional health and well-being in late-life depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

7 January 2021

Depressive disorders and other emotional issues in the elderly: current issues

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

7 January 2021

Bupropion sustained release versus paroxetine for the treatment of depression in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901337-9

7 January 2021

10.1016/S0006-3223(02)01337-9

Identifiers

DOI

1 reference

4 August 2017

1 reference